Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Patil, Sharanabasava"'
Publikováno v:
In Journal of Building Engineering 1 May 2024 84
Publikováno v:
In Journal of Building Engineering 1 May 2024 84
Publikováno v:
In Heliyon 29 February 2024 10(4)
Autor:
Patil, Sharanabasava, Ramesh, B., Sathish, T., Saravanan, A., Almujibah, Hamad, Panchal, Hitesh, Makki, Emad, Giri, Jayant
Publikováno v:
In Alexandria Engineering Journal January 2024 87:682-706
Autor:
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj, Patil Sharanabasava, Rajesh Pandey, Rakesh Lodha, Anil Kumar Pandey, Guruprasad R. Medigeshi
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-7 (2022)
Serosurveillance studies show a heterogenous mix of the Indian population with immunity to COVID-19 due to vaccination or natural infection. Here, the authors enrol subjects representative of the general population, to assess whether pre-existing ant
Externí odkaz:
https://doaj.org/article/9f137a18f4f940adb91abc76b8797ea6
Autor:
Anbalagan Anantharaj, Soon Jyoti Das, Patil Sharanabasava, Rakesh Lodha, Sushil K. Kabra, Tarun Kumar Sharma, Guruprasad R. Medigeshi
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
The gold standard for the diagnosis of SARS-CoV-2, the causative agent of COVID-19, is real-time polymerase chain reaction (PCR), which is labor-intensive, expensive, and not widely available in resource-poor settings. Therefore, it is imperative to
Externí odkaz:
https://doaj.org/article/f950b389befc4c7388f75c31eb8ddb73
Autor:
Suman Das, Janmejay Singh, Heena Shaman, Balwant Singh, Anbalagan Anantharaj, Patil Sharanabasava, Rajesh Pandey, Rakesh Lodha, Anil Kumar Pandey, Guruprasad R. Medigeshi
Most adults in India have received at least one dose of COVID-19 vaccine and also been infected naturally during the pandemic. As immunization of individuals continues under this situation where the virus has attained endemicity, we assessed whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47c04782499568ae5ba4880cc38bde82
https://doi.org/10.1101/2022.02.07.22270612
https://doi.org/10.1101/2022.02.07.22270612
Autor:
Anbalagan, Anantharaj, Sunil, Gujjar, Nikhil, Verma, Naseem Ahmed, Khan, Heena, Shaman, Patil, Sharanabasava, Asim, Das, Rajesh, Pandey, Anil Kumar, Pandey, Guruprasad R, Medigeshi
Publikováno v:
Journal of Clinical Virology
Over 90% of the COVID-19 patients manifest mild/moderate symptoms or are asymptomatic. Although comorbidities and dysregulation of immune response have been implicated in severe COVID-19, the host factors that associate with asymptomatic or mild infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926666106b8fa869d06dd6f8644301df
http://europepmc.org/articles/PMC8687718
http://europepmc.org/articles/PMC8687718
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rakesh Lodha, Soon Jyoti Das, Patil Sharanabasava, Guruprasad R. Medigeshi, Sushil K. Kabra, Tarun Kumar Sharma, Anbalagan Anantharaj
Publikováno v:
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences, Vol 7 (2020)
Frontiers in Molecular Biosciences, Vol 7 (2020)
The gold standard for the diagnosis of SARS-CoV-2, the causative agent of COVID-19, is real-time polymerase chain reaction (PCR), which is labor-intensive, expensive, and not widely available in resource-poor settings. Therefore, it is imperative to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d582636f1a67a1b8d5ede9c483b055c
https://doi.org/10.3389/fmolb.2020.586254
https://doi.org/10.3389/fmolb.2020.586254